Coronavirus Notebook: WHO Backs Actemra & Kevzara In COVID-19, German Body Says Remdesivir Has ‘Considerable Added Benefit’
The UK REACT-1 study has shown a threefold reduction in COVID-19 infections in double-vaccinated adults.

The UK REACT-1 study has shown a threefold reduction in COVID-19 infections in double-vaccinated adults.